235 related articles for article (PubMed ID: 18210153)
1. Effect of in vivo loss of GDF-15 on hepatocellular carcinogenesis.
Zimmers TA; Jin X; Gutierrez JC; Acosta C; McKillop IH; Pierce RH; Koniaris LG
J Cancer Res Clin Oncol; 2008 Jul; 134(7):753-9. PubMed ID: 18210153
[TBL] [Abstract][Full Text] [Related]
2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
3. Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis.
Ding Z; Ericksen RE; Escande-Beillard N; Lee QY; Loh A; Denil S; Steckel M; Haegebarth A; Wai Ho TS; Chow P; Toh HC; Reversade B; Gruenewald S; Han W
J Hepatol; 2020 Apr; 72(4):725-735. PubMed ID: 31726117
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-26a systemic administration attenuates tumor formation in hepatocellular carcinoma mouse model.
Badr AM; El-Ahwany E; Goda L; Nagy F; Helal N; El Deeb S
Pak J Pharm Sci; 2021 May; 34(3):925-932. PubMed ID: 34602415
[TBL] [Abstract][Full Text] [Related]
5. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
6. Liver specific overexpression of platelet-derived growth factor-B accelerates liver cancer development in chemically induced liver carcinogenesis.
Maass T; Thieringer FR; Mann A; Longerich T; Schirmacher P; Strand D; Hansen T; Galle PR; Teufel A; Kanzler S
Int J Cancer; 2011 Mar; 128(6):1259-68. PubMed ID: 20506153
[TBL] [Abstract][Full Text] [Related]
7. Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide.
Pittala S; Krelin Y; Shoshan-Barmatz V
Neoplasia; 2018 Jun; 20(6):594-609. PubMed ID: 29747160
[TBL] [Abstract][Full Text] [Related]
8. Abberent expression of NOR1 protein in tumor associated macrophages contributes to the development of DEN-induced hepatocellular carcinoma.
Chen S; Zheng P; Wang W; Yi M; Chen P; Cai J; Li J; Peng Q; Ban Y; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Jun; 233(6):5002-5013. PubMed ID: 29227538
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing hepatitis B virus X protein are more susceptible to carcinogen induced hepatocarcinogenesis.
Zhu H; Wang Y; Chen J; Cheng G; Xue J
Exp Mol Pathol; 2004 Feb; 76(1):44-50. PubMed ID: 14738868
[TBL] [Abstract][Full Text] [Related]
10. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats.
Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE
Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337
[TBL] [Abstract][Full Text] [Related]
11. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
12. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
13. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein homologous (CHOP) protein promotes carcinogenesis in the DEN-induced hepatocellular carcinoma model.
Scaiewicz V; Nahmias A; Chung RT; Mueller T; Tirosh B; Shibolet O
PLoS One; 2013; 8(12):e81065. PubMed ID: 24339898
[TBL] [Abstract][Full Text] [Related]
15. Pantoprazole suppresses carcinogenesis and growth of hepatocellular carcinoma by inhibiting glycolysis and Na
Jin H; Wen G; Zhu J; Liu J; Li J; Yao S; Zhao Z; Dong Z; Zhang X; An J; Liu X; Tuo B
Drug Dev Res; 2024 Jun; 85(4):e22198. PubMed ID: 38764200
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of diethylnitrosamine to induce hepatocarcinogenesis and to evaluate its synergistic effect with other hepatotoxins in mice.
Fuentes-Hernández S; Alarcón-Sánchez BR; Guerrero-Escalera D; Montes-Aparicio AV; Castro-Gil MP; Idelfonso-García OG; Rosas-Madrigal S; Aparicio-Bautista DI; Pérez-Hernández JL; Reyes-Gordillo K; Lakshman MR; Vásquez-Garzón VR; Baltiérrez-Hoyos R; López-González ML; Sierra-Santoyo A; Villa-Treviño S; Pérez-Carreón JI; Arellanes-Robledo J
Toxicol Appl Pharmacol; 2019 Sep; 378():114611. PubMed ID: 31176654
[TBL] [Abstract][Full Text] [Related]
18. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis.
Mayhew CN; Carter SL; Fox SR; Sexton CR; Reed CA; Srinivasan SV; Liu X; Wikenheiser-Brokamp K; Boivin GP; Lee JS; Aronow BJ; Thorgeirsson SS; Knudsen ES
Gastroenterology; 2007 Sep; 133(3):976-84. PubMed ID: 17854601
[TBL] [Abstract][Full Text] [Related]
19. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
20. Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice.
Lin H; Yan J; Wang Z; Hua F; Yu J; Sun W; Li K; Liu H; Yang H; Lv Q; Xue J; Hu ZW
Hepatology; 2013 Jan; 57(1):171-82. PubMed ID: 22859216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
